Covaxin gets emergency use approval for kids aged 2-18 years
New Delhi, Oct 12 : The Hyderabad-based pharma major Bharat Biotech’s Covaxin has got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India (DCGA).The Subject Expert Committee on Covid-19…